Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-27), Teladoc Health's 9-Day RSI is 43.59.
The industry rank for Teladoc Health's 9-Day RSI or its related term are showing as below:
MEX:TDOC's 9-Day RSI is ranked better than 56.53% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 45.6
vs MEX:TDOC: 43.59
Teladoc Health (MEX:TDOC) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Teladoc Health 9-Day RSI Related Terms
MEX:TDOC vs OMCL, OMDA, CERT: 9-Day RSI Comparison
For the Health Information Services subindustry, Teladoc Health's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teladoc Health 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Teladoc Health's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health (MEX:TDOC) has a 9-Day RSI of 43.59 as of Jul. 27, 2026. According to the industry distribution chart, Teladoc Health ranks #303 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 43.5%.
Is Teladoc Health's 9-Day RSI too high?
Teladoc Health's current 9-Day RSI is 43.59. The Healthcare Providers & Services industry median 9-Day RSI is 45.60. Teladoc Health's value of 43.59 is 4.4% below this industry median. Based on the distribution chart, Teladoc Health ranks #303 out of 697 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Teladoc Health has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's 9-Day RSI compare to OMCL and OMDA?
According to the Healthcare Providers & Services industry distribution chart, Teladoc Health ranks #303 out of 697 companies for 9-Day RSI. This puts Teladoc Health in the upper half of its industry. The industry median 9-Day RSI is 45.60. Teladoc Health's value of 43.59 is 4.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 45.60, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teladoc Health's current 9-Day RSI of 43.59 is 4.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 45.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teladoc Health's current 9-Day RSI is 43.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (MEX:TDOC) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN138.36, compared to a current price of MXN154.00 — trading 11.3% above its estimated fair value. The current 9-Day RSI is 43.59 and 4.4% below the Healthcare Providers & Services industry median of 45.60. Teladoc Health's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Teladoc Health (MEX:TDOC), the current 9-Day RSI is 43.59 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teladoc Health (MEX:TDOC) Overvalued in 2026?
Based on GuruFocus' analysis, Teladoc Health stock appears to be overvalued.
The current stock price of MXN154.00 is trading 11.3% above its estimated GF Value™ of MXN138.36.
GuruFocus considers Teladoc Health to be Modestly Overvalued.
Key valuation signals for MEX:TDOC:
9-Day RSI: 43.59
GF Value™: MXN138.36 vs. price of MXN154.00 (11.3% above fair value)
Industry Position: 4.4% below the Healthcare Providers & Services median (#303 of 697)
No single metric tells the full story. See the MEX:TDOC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
52GF Score
Get the complete analysis for MEX:TDOC
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TDOC has been successfully added to your 
